Terns Pharmaceuticals Inc. Gains 45.7%

Mon, Aug 15, 2022 at 07:00 PM

Terns Pharmaceuticals Inc. (TERN:NASDAQ) shot up at $4.4, a gain of 45.7%. On Mon, Aug 15, 2022, TERN:NASDAQ touched a New 2-Week High of $4.4. The stock appeared on our News Catalysts scanner on Mon, Aug 08, 2022 at 04:34 PM in the 'EARNINGS' category. From Mon, Aug 01, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days

About Terns Pharmaceuticals Inc. (TERN:NASDAQ)

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company.

Top 10 Gainers:

Magic Empire Global Limited (MEGL:NASDAQ), 115.69%
MiNK Therapeutics Inc. (INKT:NASDAQ), 98.83%
Regis Corporation (RGS:NYSE), 75.15%
Team, Inc. (TISI:NYSE), 57.79%
Viridian Therapeutics Inc. (VRDN:NASDAQ), 49.36%
Terns Pharmaceuticals Inc. (TERN:NASDAQ), 45.7%
GigaMedia Limited (GIGM:NASDAQ), 41.46%
Revlon, Inc. (REV:NYSE), 30.64%
Qualtek Services Inc Cl A (QTEK:NASDAQ), 28.82%
RCM Technologies, Inc. (RCMT:NASDAQ), 26.82%